Is a complete RLAY research report available?

No complete published report is available for Relay Therapeutics, Inc. (RLAY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · USD

$18.4

-0.65 (-3.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RLAY analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4B
Revenue (ttm)	10.7M
Net income (ttm)	-272.7M
EPS (ttm)	-$1.57
Shares out	217.9M
Volume	2,039,927
Beta	1.68
Price target	$26.1	+41.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.7M
Net income (ttm): -272.7M
EPS (ttm): -$1.57
Market cap: 4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RLAY indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001812364
Company name	Relay Therapeutics, Inc.
Country	United States
Country code	US
Cusip	75943R102
Employees	193
Employees Change	-66%
Employees Change Percent	-25.48
Enterprise value	$3.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-07-16
Isin	US75943R1023
Last refreshed	2026-07-25
Market cap	$4B
Market cap category	Mid-Cap
Price	$18.44
Price currency	USD
Rev Per Employee	55,316.06x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	RLAY
Website	https://www.relaytx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.79%
EV Sales Forward	354.11x
EV/Sales	319.25x
FCF yield	-5.31%
P/B ratio	5.62x
P/S ratio	376.43x
PS Forward	417.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2,776.6%
EBITDA Margin	-2,749.88%
Gross Profit	$-245.6M
Net Income	$-272.7M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-2,554.37%
Profit Per Employee	$-1.4M
ROA	-24.72
Roa5y	-22.39
ROCE	-44.26
ROE	-40.01
Roe5y	-40.14
ROIC	-25.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	387.07%
Cagr3y	14.17%
Cagr5y	-11.64%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth	39.03x
Revenue Growth Q	-60.93x
Revenue Growth Years	1x
Revenue Growth3 Y	107.9x
Revenue Growth5 Y	-33.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$699.6M
Cash	$642.1M
Current Assets	$658.5M
Current Liabilities	$29.8M
Debt	$31.6M
Debt Equity	$0.05
Equity	$642.2M
Liabilities	$57.4M
Long Term Assets	$41.2M
Long Term Liabilities	$27.7M
Net Cash	$610.5M
Net Cash By Market Cap	$15.19
Net Cash Growth	-7.95%
Net Debt Equity	$-0.95
Tangible Book Value	$642.2M
Tangible Book Value Per Share	$3.39
WACC	13.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.13
Net Working Capital	$-9.5M
Quick ratio	21.58
Working Capital	$628.7M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	386.54%
200-day SMA	11.04
3Y total return	48.83%
50-day SMA	16.38
50-day SMA vs 200-day SMA	50over200
5Y total return	-46.14%
All Time High	64.37
All Time High Change	-71.35%
All Time High Date	2021-01-20
All Time Low	1.78
All Time Low Change	938.87%
All Time Low Date	2025-04-07
ATR	1.14
Beta	1.68
Beta1y	1.81
Beta2y	2.07
Ch YTD	118
High	19.29
High52	20.79
High52 Date	2026-07-09
High52ch	-11.3%
Low	18.26
Low52	3.03
Low52 Date	2025-08-08
Low52ch	509.59%
Ma50ch	12.56%
Premarket Change Percent	0.58
Premarket Price	$19.2
Premarket Volume	5,609
Price vs 200-day SMA	67.01%
RSI	51.07
RSI Monthly	72.2
RSI Weekly	68.34
Sharpe ratio	2.53x
Sortino ratio	4.78
Total Return	-14.28%
Tr YTD	118
Tr1m	5.73%
Tr1w	-7.38%
Tr3m	22.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	9
Analyst Price Target Top	$23.88
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.4
Earnings Revenue Estimate	1,028,000x
Earnings Revenue Estimate Growth	51.85x
Operating Income	$-296.5M
Operating margin	-2,776.9
Price target	$26.08
Price Target Change	$41.43
Price Target Change Top	$29.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,866,449%
Float Percent	71.06%
Shares Insiders	1.72%
Shares Institutions	54.18%
Shares Out	217,940,332
Shares Qo Q	3.72%
Shares Yo Y	14.28%
Short Float	27.79%
Short Ratio	8.72
Short Shares	19.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-267M
Average Volume	3,435,457x
Bv Per Share	3.39
CAPEX	$-26,000
Ch1m	5.73
Ch1w	-7.38
Ch1y	386.5
Ch3m	22.2
Ch3y	48.83
Ch5y	-46.14
Ch6m	148.2
Change	-3.4%
Change From Open	-3.86
Close	19.09
Days Gap	0.47
Depreciation Amortization	2,853,000
Dollar Volume	37,616,253.9
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-296.5M
EBITDA	$-293.6M
EPS	$-1.57
F Score	4
FCF	$-213.4M
FCF EV Yield	-6.26x
FCF Per Share	$-0.98
Financing CF	140,386,000
Fiscal Year End	December
Founded	2,015
Investing CF	183,235,000
Ipr	-7.8
Iprfo	-47.31
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	12.38
Ma150ch	48.95%
Ma20	19.22
Ma20ch	-4.04%
Net CF	110,264,000
Next Earnings Date	2026-08-06
Open	19.18
Optionable	Yes
Position In Range	17.48
Post Close	18.44
Postmarket Change Percent	-1.38
Postmarket Price	$18.19
Ppne	39,815,000
Pre Close	19.09
Price Date	2026-07-24
Ptbv Ratio	6.26
Relative Volume	0.59x
Revenue	10,676,000x
SBC By Revenue	502.35x
Share Based Comp	53,631,000
Tr6m	148.18%
Us State	Massachusetts
Volume	2,039,927
Z Score	5.86

Relay Therapeutics, Inc. (RLAY)

Coverage state: Market snapshot only — no published research

Generate the first RLAY analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RLAY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RLAY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RLAY

Frequently asked questions